Physiological Effects of Drugs
44
7
9
22
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.5%
2 terminated out of 44 trials
91.7%
+5.2% vs benchmark
36%
16 trials in Phase 3/4
36%
8 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (44)
Effectiveness of the Comfort-In Needle Free Injection System During Palatal Infiltrative Anesthesia
Natural History of Depression, Bipolar Disorder and Suicide Risk
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)
Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study
Antidiabetic Drugs for Steatotic Liver Disease
Behavior Brain Responses
Natural Killer Cell (CYNK-001) Infusions in Adults with AML
Omalizumab to Accelerate a Symptom-driven Multi-food OIT
Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex
Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial